CJ Bioscience, Inc. (KOSDAQ:311690)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,550.00
+50.00 (1.43%)
At close: Nov 13, 2026

CJ Bioscience Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
46,382121,770131,831147,076170,481286,048
Market Cap Growth
-62.23%-7.63%-10.37%-13.73%-40.40%43.54%
Enterprise Value
13,31374,17998,118116,989139,502291,080
Last Close Price
3550.009320.0010090.0016140.0024887.5141793.85

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
12.6132.9838.0326.3841.8465.56
PB Ratio
1.112.271.702.063.433.26
P/TBV Ratio
1.552.912.022.493.513.26

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
3.6220.0928.3020.9834.2466.72

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.190.190.120.120.580.27
Net Debt / Equity Ratio
-0.79-0.75-0.85-0.78-0.41-0.64
Net Debt / EBITDA Ratio
1.731.952.202.070.696.58
Net Debt / FCF Ratio
1.671.732.341.860.815.98
Asset Turnover
0.050.040.040.060.040.05
Inventory Turnover
14.6119.5022.2132.5024.9010.67
Quick Ratio
2.763.554.104.381.433.39
Current Ratio
2.883.614.144.431.463.42
Return on Equity (ROE)
-41.76%-36.54%-44.00%-37.82%-50.78%-31.51%
Return on Assets (ROA)
-20.11%-18.02%-22.44%-21.95%-20.00%-6.66%
Return on Capital Employed (ROCE)
-50.50%-42.90%-42.20%-42.00%-58.90%-10.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-48.14%-19.71%-24.91%-15.58%-20.48%-6.74%
FCF Yield
-42.66%-19.24%-21.34%-20.28%-14.73%-3.28%
Buyback Yield / Dilution
-16.13%-40.88%-30.93%-20.52%-38.23%-10.14%